3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pleural Diseases
2
Pancreatic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Non-Muscle Invasive Bladder Neoplasms
1
Mesothelioma, Malignant
1
Glioma
1
Glioblastoma
1
Epitheliod Malignant Pleural Mesothelioma
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Basal Cell
1
Interventions
pembrolizumab
119
Cisplatin
33
lenvatinib
29
Carboplatin
28
Paclitaxel
27
Docetaxel
14
Pemetrexed
13
Fluorouracil
12
Capecitabine
11
Saline Solution
10
Oxaliplatin
10
Gemcitabine
10
Albumin-Bound Paclitaxel
7
olaparib
6
Leucovorin
6
Bevacizumab
6
epacadostat
5
belzutifan
5
Etoposide
5
Cetuximab
5
130-nm albumin-bound paclitaxel
5
trifluridine tipiracil drug combination
3
regorafenib
3
patritumab deruxtecan
3
enzalutamide
3
enfortumab vedotin
3
durvalumab
3
Surgical Procedures, Operative
3
Radiotherapy
3
Levoleucovorin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
1-phenyl-3,3-dimethyltriazene
×
1 year
×
Clear all
No trials found.